Nov 11, 2021 / 01:00PM GMT
Jo Walton - Crédit Suisse AG - Research Division - MD
Good morning to those of you in the U.S. Good afternoon to those of you in Europe. It's my pleasure with my colleague, Dominic Lunn here, to welcome Bayer to the fireside chat within our health care conference. I'm pleased to say that we've got Stefan Oelrich, the CEO. We've got Axel Hamann, the CFO; and Christian Rommel in R&D. And we also have Juergen to keep us on the straight and narrow from IR.
Dominic and I will ask questions. If anyone in the audience has any particular questions that you feel that we're missing out and wants asked. Do please e-mail either myself, [email protected] or my colleague, Dominic, [email protected] and we can make sure that those questions are asked.
Questions and Answers:
Jo Walton - Crédit Suisse AG - Research Division - MDAnd so with that, if I may start off, please, and ask a topical one on health care reform. Lots of people are asking for reactions from companies to what